| Product Code: ETC9946673 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United Kingdom import momentum for insulin drugs & devices experienced a growth rate of 0.67%, with a compound annual growth rate (CAGR) of 2.33% from 2020 to 2024. This moderate growth can be attributed to stable demand and market conditions, indicating a consistent pattern in the United Kingdom healthcare sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Insulin Drugs & Devices Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Insulin Drugs & Devices Market - Industry Life Cycle |
3.4 United Kingdom (UK) Insulin Drugs & Devices Market - Porter's Five Forces |
3.5 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Drugs, 2022 & 2032F |
3.6 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume Share, By Combination drugs, 2022 & 2032F |
3.7 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume Share, By Non-Insulin Injectable drugs, 2022 & 2032F |
3.8 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Device, 2022 & 2032F |
4 United Kingdom (UK) Insulin Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the United Kingdom |
4.2.2 Technological advancements in insulin drugs and devices |
4.2.3 Growing awareness about diabetes management and treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin drugs and devices |
4.3.2 High cost associated with insulin therapy |
4.3.3 Limited access to healthcare services in certain regions of the UK |
5 United Kingdom (UK) Insulin Drugs & Devices Market Trends |
6 United Kingdom (UK) Insulin Drugs & Devices Market, By Types |
6.1 United Kingdom (UK) Insulin Drugs & Devices Market, By Insulin Drugs |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Insulin Drugs, 2022-2032F |
6.1.3 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Basal or Long Acting Insulins, 2022-2032F |
6.1.4 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Bolus or Fast Acting Insulins, 2022-2032F |
6.1.5 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Traditional Human Insulins, 2022-2032F |
6.1.6 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Biosimilar Insulins, 2022-2032F |
6.2 United Kingdom (UK) Insulin Drugs & Devices Market, By Combination drugs |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Insulin combinations, 2022-2032F |
6.2.3 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Oral Combinations, 2022-2032F |
6.3 United Kingdom (UK) Insulin Drugs & Devices Market, By Non-Insulin Injectable drugs |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By GLP-1 receptor agonists, 2022-2032F |
6.3.3 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Amylin Analogue, 2022-2032F |
6.4 United Kingdom (UK) Insulin Drugs & Devices Market, By Insulin Device |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pumps, 2022-2032F |
6.4.3 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pens, 2022-2032F |
6.4.4 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Insulin Syringes, 2022-2032F |
6.4.5 United Kingdom (UK) Insulin Drugs & Devices Market Revenues & Volume, By Insulin Jet Injectors, 2022-2032F |
7 United Kingdom (UK) Insulin Drugs & Devices Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Insulin Drugs & Devices Market Export to Major Countries |
7.2 United Kingdom (UK) Insulin Drugs & Devices Market Imports from Major Countries |
8 United Kingdom (UK) Insulin Drugs & Devices Market Key Performance Indicators |
8.1 Adoption rate of new insulin drugs and devices |
8.2 Patient satisfaction with insulin therapy options |
8.3 Rate of diabetes complications among patients in the UK |
9 United Kingdom (UK) Insulin Drugs & Devices Market - Opportunity Assessment |
9.1 United Kingdom (UK) Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Drugs, 2022 & 2032F |
9.2 United Kingdom (UK) Insulin Drugs & Devices Market Opportunity Assessment, By Combination drugs, 2022 & 2032F |
9.3 United Kingdom (UK) Insulin Drugs & Devices Market Opportunity Assessment, By Non-Insulin Injectable drugs, 2022 & 2032F |
9.4 United Kingdom (UK) Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Device, 2022 & 2032F |
10 United Kingdom (UK) Insulin Drugs & Devices Market - Competitive Landscape |
10.1 United Kingdom (UK) Insulin Drugs & Devices Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Insulin Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here